Ikarian Capital, LLC
- SEC CIK
- 0001778253
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed Aug 18, 2021. Long positions only.
- Positions
- 178
- No 13F data for Q4 2020
- Portfolio value
- $671.6M
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | Stock | 125,000 | $23.4M | 3.5% | – | – | History |
| XFORX4 Pharmaceuticals, Inc | COM | 2,614,988 | $22.5M | 3.4% | – | – | History |
| TCONTracon Pharmaceuticals, Inc. | COM NEW | 2,716,840 | $22.4M | 3.3% | – | – | History |
| MGNXMacrogenics Inc | COM | 500,469 | $15.9M | 2.4% | – | – | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 200,000 | $15.5M | 2.3% | – | – | History |
| CMRXChimerix Inc | COM | 1,597,514 | $15.4M | 2.3% | – | – | History |
| CRISCuris Inc | COM NEW | 1,220,356 | $13.8M | 2.1% | – | – | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 596,290 | $12.3M | 1.8% | – | – | History |
| TVRDTvardi Therapeutics, Inc. | COM | 558,524 | $12.1M | 1.8% | – | – | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 250,000 | $12.1M | 1.8% | – | – | History |
| XENEXenon Pharmaceuticals Inc. | COM | 640,576 | $11.5M | 1.7% | – | – | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 330,989 | $11.2M | 1.7% | – | – | History |
| PRTAProthena Corp Public Ltd Co | SHS | 437,430 | $11.0M | 1.6% | – | – | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 1,836,545 | $10.6M | 1.6% | – | – | History |
| TARAProtara Therapeutics, Inc. | COM STK | 649,542 | $10.2M | 1.5% | – | – | History |
| RLMDRelmada Therapeutics, Inc. | COM | 290,207 | $10.2M | 1.5% | – | – | History |
| PCVXVaxcyte, Inc. | COM | 501,110 | $9.90M | 1.5% | – | – | History |
| GOSSGossamer Bio, Inc. | COM | 1,048,383 | $9.70M | 1.4% | – | – | History |
| IRONDisc Medicine, Inc. | COM | 684,379 | $9.27M | 1.4% | – | – | History |
| LYRALyra Therapeutics, Inc. | COM | 780,728 | $9.05M | 1.3% | – | – | History |
| SCPHscPharmaceuticals Inc. | COM | 1,308,699 | $8.70M | 1.3% | – | – | History |
| VINCVincerx Pharma, Inc. | COM NEW | 438,684 | $8.47M | 1.3% | – | – | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 225,926 | $8.32M | 1.2% | – | – | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 62,090 | $8.00M | 1.2% | – | – | History |
| EPIXESSA Pharma Inc. | COM NEW | 264,868 | $7.69M | 1.1% | – | – | History |
| SRRASierra Oncology, Inc. | COM NEW | 445,188 | $7.67M | 1.1% | – | – | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 296,965 | $7.63M | 1.1% | – | – | History |
| MCRBSeres Therapeutics, Inc. | COM | 350,000 | $7.21M | 1.1% | – | – | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 1,256,048 | $7.20M | 1.1% | – | – | History |
| OCULOcular Therapeutix, Inc | COM | 419,573 | $6.88M | 1.0% | – | – | History |
| SAGESage Therapeutics, Inc. | COM | 91,151 | $6.82M | 1.0% | – | – | History |
| ARDXArdelyx, Inc. | COM | 1,030,436 | $6.82M | 1.0% | – | – | History |
| VSTMVerastem, Inc. | COM | 2,694,394 | $6.66M | 1.0% | – | – | History |
| LRMRLarimar Therapeutics, Inc. | COM | 425,384 | $6.21M | 0.9% | – | – | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,885,952 | $6.15M | 0.9% | – | – | History |
| HARPHarpoon Therapeutics, Inc. | COM | 268,600 | $5.62M | 0.8% | – | – | History |
| STTKShattuck Labs, Inc. | COM | 190,330 | $5.57M | 0.8% | – | – | History |
| ANVSAnnovis Bio, Inc. | COM | 193,368 | $5.39M | 0.8% | – | – | History |
| SYBXSynlogic, Inc. | COM | 1,492,614 | $5.34M | 0.8% | – | – | History |
| SNCEScience 37 Holdings, Inc. | COM | 512,450 | $5.20M | 0.8% | – | – | History |
| ALECAlector, Inc. | COM | 257,500 | $5.18M | 0.8% | – | – | History |
| FULCFulcrum Therapeutics, Inc. | COM | 426,739 | $5.03M | 0.7% | – | – | History |
| CLVSClovis Oncology, Inc. | COM | 679,473 | $4.77M | 0.7% | – | – | History |
| ACRSAclaris Therapeutics, Inc. | COM | 188,200 | $4.74M | 0.7% | – | – | History |
| ICADIcad Inc | COM NEW | 217,637 | $4.62M | 0.7% | – | – | History |
| VKTXViking Therapeutics, Inc. | COM | 724,754 | $4.58M | 0.7% | – | – | History |
| ODTOdonate Therapeutics, Inc. | COM | 1,336,412 | $4.57M | 0.7% | – | – | History |
| NXTCNextCure, Inc. | COM | 453,952 | $4.54M | 0.7% | – | – | History |
| OVIDOvid Therapeutics Inc. | COM | 1,124,872 | $4.52M | 0.7% | – | – | History |
| Chardan Healthcr Acqstn 2 Co15957T206 | UNIT 99/99/9999 | 400,000 | $4.40M | 0.7% | – | – | – |
| CABACabaletta Bio, Inc. | COM | 389,384 | $4.32M | 0.6% | – | – | History |
| PLRXPliant Therapeutics, Inc. | COM | 108,700 | $4.28M | 0.6% | – | – | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 111,500 | $4.12M | 0.6% | – | – | History |
| TCDATricida, Inc. | COM | 775,294 | $4.10M | 0.6% | – | – | History |
| RNTXRein Therapeutics, Inc. | COM | 2,800,000 | $4.00M | 0.6% | – | – | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 676,294 | $4.00M | 0.6% | – | – | History |
| KAKineta, Inc. | COM | 219,470 | $3.97M | 0.6% | – | – | History |
| ONCTOncternal Therapeutics, Inc. | COM | 460,323 | $3.83M | 0.6% | – | – | History |
| DMACDiaMedica Therapeutics Inc. | COM NEW | 415,000 | $3.80M | 0.6% | – | – | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 100,000 | $3.76M | 0.6% | – | – | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 153,941 | $3.73M | 0.6% | – | – | History |
| KDMNKadmon Holdings, Inc. | COM | 936,615 | $3.64M | 0.5% | – | – | History |
| ALLKAllakos Inc. | COM | 31,700 | $3.64M | 0.5% | – | – | History |
| SEELSeelos Therapeutics, Inc. | COM | 718,284 | $3.58M | 0.5% | – | – | History |
| BCABBioAtla, Inc. | COM | 70,160 | $3.57M | 0.5% | – | – | History |
| SVRASavara Inc | COM | 1,714,366 | $3.57M | 0.5% | – | – | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 2,651,093 | $3.42M | 0.5% | – | – | History |
| SRRKScholar Rock Holding Corp | COM | 67,059 | $3.40M | 0.5% | – | – | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 322,730 | $3.39M | 0.5% | – | – | History |
| FOLDAmicus Therapeutics, Inc. | COM | 341,500 | $3.37M | 0.5% | – | – | History |
| BCTG Acquisition Corp05492W103 | COM | 300,250 | $3.34M | 0.5% | – | – | – |
| ACHVAchieve Life Sciences, Inc. | COM | 284,151 | $3.29M | 0.5% | – | – | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 304,739 | $3.23M | 0.5% | – | – | History |
| SBBPStrongbridge Biopharma plc | SHS USD | 1,160,450 | $3.20M | 0.5% | – | – | History |
| MORFMorphic Holding, Inc. | COM | 49,925 | $3.16M | 0.5% | – | – | History |
| Highcape Cap Acquisition Cor42984L105 | COM CL A | 260,000 | $3.10M | 0.5% | – | – | – |
| STROSutro Biopharma, Inc. | COM | 135,360 | $3.08M | 0.5% | – | – | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 1,268,154 | $3.04M | 0.5% | – | – | History |
| TCRRTCR2 Therapeutics Inc. | COM | 136,486 | $3.01M | 0.4% | – | – | History |
| CYTKCytokinetics Inc | COM NEW | 127,000 | $2.95M | 0.4% | – | – | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 581,200 | $2.93M | 0.4% | – | – | History |
| IMTXImmatics N.V. | SHS | 255,138 | $2.86M | 0.4% | – | – | History |
| INMBInmune Bio, Inc. | COM | 233,576 | $2.77M | 0.4% | – | – | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 23,654 | $2.77M | 0.4% | – | – | History |
| IFRXInflaRx N.V. | COM | 699,750 | $2.73M | 0.4% | – | – | History |
| AVTXAvalo Therapeutics, Inc. | COM | 897,330 | $2.71M | 0.4% | – | – | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 250,000 | $2.68M | 0.4% | – | – | History |
| NUVBNuvation Bio Inc. | COM CL A | 250,000 | $2.61M | 0.4% | – | – | History |
| ALTAltimmune, Inc. | COM NEW | 181,941 | $2.57M | 0.4% | – | – | History |
| LQDALiquidia Corp | COM NEW | 951,400 | $2.56M | 0.4% | – | – | History |
| PASGPassage BIO, Inc. | COM | 145,858 | $2.55M | 0.4% | – | – | History |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 852,998 | $2.46M | 0.4% | – | – | – |
| ZGNXZogenix, Inc. | COM NEW | 124,091 | $2.42M | 0.4% | – | – | History |
| FNCHFinch Therapeutics Group, Inc. | COM | 150,000 | $2.39M | 0.4% | – | – | History |
| MRUSMerus N.V. | COM | 111,223 | $2.32M | 0.3% | – | – | History |
| ZLABZai Lab Ltd | ADR | 17,000 | $2.25M | 0.3% | – | – | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 200,000 | $2.25M | 0.3% | – | – | History |
| Bio Green Med Solution, Inc.23254L603 | COM | 300,000 | $2.13M | 0.3% | – | – | – |
| AGTCApplied Genetic Technologies Corp | COM | 415,884 | $2.11M | 0.3% | – | – | History |
| RGLSRegulus Therapeutics Inc. | COM NEW | 1,245,989 | $1.94M | 0.3% | – | – | History |
Options (98)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $218.0M | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $128.9M | $47.5M |
| ARK Innovation ETF00214Q104 | ETF | $131.9M | – |
| BIIBBiogen Inc. | COM | – | $110.5M |
| iShares Russell 2000 ETF464287655 | ETF | $99.4M | – |
| iShares Tr464287432 | 20 YR TR BD ETF | $40.6M | $54.2M |
| MRNAModerna, Inc. | Stock | $78.6M | $13.1M |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | $75.8M | – |
| Invesco QQQ Trust Series I46090E103 | ETF | $63.8M | – |
| ONCBeOne Medicines Ltd. | ADR | $55.9M | $3.65M |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | – | $58.2M |
| State Street Industrial Select Sector SPDR ETF81369Y704 | ETF | – | $49.2M |
| NVAXNovavax Inc | COM NEW | $35.5M | $12.7M |
| MRTXMirati Therapeutics, Inc. | COM | $27.8M | $16.2M |
| VRTXVertex Pharmaceuticals Inc | Stock | $43.0M | – |
| iShares Semiconductor ETF464287523 | ETF | $42.4M | – |
| Curevac N VN2451R105 | COM | $32.9M | $9.14M |
| SRPTSarepta Therapeutics, Inc. | COM | $34.0M | $7.45M |
| State Street Financial Select Sector SPDR ETF81369Y605 | ETF | – | $37.8M |
| iShares Tr464287556 | ISHARES BIOTECH | – | $37.6M |
| ChemoCentryx, Inc.16383L106 | COM | $26.2M | $10.2M |
| BEAMBeam Therapeutics Inc. | COM | $28.8M | – |
| GILDGilead Sciences, Inc. | Stock | – | $28.7M |
| EXASExact Sciences Corp | COM | $27.0M | – |
| SAGESage Therapeutics, Inc. | COM | $18.7M | $7.80M |
| GW Pharmaceuticals PLC36197T103 | ADS | $25.8M | – |
| BHCBausch Health Companies Inc. | Stock | – | $25.4M |
| VanEck Semiconductor ETF92189F676 | ETF | $24.4M | – |
| IGMSIGM Biosciences, Inc. | COM | $19.2M | – |
| TVRDTvardi Therapeutics, Inc. | COM | – | $18.4M |
| UTHRUnited Therapeutics Corp | COM | – | $17.6M |
| AZNAstraZeneca PLC | SPONSORED ADR | – | $17.4M |
| ARGXArgenx SE | SPONSORED ADR | $9.50M | $7.41M |
| ZGNXZogenix, Inc. | COM NEW | – | $16.6M |
| JAZZJazz Pharmaceuticals plc | SHS USD | – | $16.4M |
| INCYIncyte Corp | COM | – | $16.3M |
| MCRBSeres Therapeutics, Inc. | COM | – | $16.1M |
| BABoeing Co | Stock | – | $15.3M |
| ACADAcadia Pharmaceuticals Inc | COM | $14.9M | – |
| TWSTTwist Bioscience Corp | COM | $14.9M | – |
| VIRVir Biotechnology, Inc. | COM | $12.8M | – |
| State Street Utilities Select Sector SPDR ETF81369Y886 | ETF | – | $12.8M |
| TXG10x Genomics, Inc. | CL A COM | $12.7M | – |
| BPMCBlueprint Medicines Corp | COM | $11.7M | – |
| RETAReata Pharmaceuticals Inc | CL A | $10.5M | – |
| KYNBKyntra Bio, Inc. | COM | $10.4M | – |
| ARNAArena Pharmaceuticals Inc | COM NEW | – | $10.4M |
| CLDXCelldex Therapeutics, Inc. | COM NEW | – | $10.4M |
| IMVTImmunovant, Inc. | COM | $3.90M | $5.80M |
| ITCIIntra-Cellular Therapies, Inc. | COM | $2.54M | $7.13M |
| ALLKAllakos Inc. | COM | $4.33M | $4.93M |
| FATEFate Therapeutics Inc | COM | $8.98M | – |
| LKFTLakefront Biotherapeutics NV | SPON ADR | – | $7.71M |
| NVTAInvitae Corp | COM | $7.64M | – |
| SDGRSchrodinger, Inc. | COM | $7.63M | – |
| ADCTADC Therapeutics SA | SHS | – | $7.32M |
| RLMDRelmada Therapeutics, Inc. | COM | – | $6.96M |
| RCUSArcus Biosciences, Inc. | COM | $6.89M | – |
| RVMDRevolution Medicines, Inc. | COM | – | $6.88M |
| ASNDAscendis Pharma A/S | SPONSORED ADR | – | $6.53M |
| BTAIQBioXcel Therapeutics, Inc. | COM | – | $6.47M |
| AGIOAgios Pharmaceuticals, Inc. | COM | – | $6.46M |
| MGNXMacrogenics Inc | COM | – | $6.37M |
| Advisorshares Tr00768Y453 | PURE US CANN ETF | – | $6.36M |
| IOVAIovance Biotherapeutics, Inc. | COM | $6.33M | – |
| RAPTRAPT Therapeutics, Inc. | COM | – | $5.55M |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | $5.11M | – |
| TGTXTG Therapeutics, Inc. | COM | $4.82M | – |
| KLRSKalaris Therapeutics, Inc. | COM | – | $4.68M |
| STROSutro Biopharma, Inc. | COM | – | $4.55M |
| OCULOcular Therapeutix, Inc | COM | – | $4.30M |
| Translate Bio, Inc.89374L104 | COM | $4.12M | – |
| ALLOAllogene Therapeutics, Inc. | COM | – | $4.12M |
| IONSIonis Pharmaceuticals Inc | COM | – | $4.05M |
| STOKStoke Therapeutics, Inc. | COM | $3.96M | – |
| KURAKura Oncology, Inc. | COM | – | $3.96M |
| ANABAnaptysbio, Inc | COM | – | $3.92M |
| CRDFCardiff Oncology, Inc. | COM | $3.87M | – |
| MRSNMersana Therapeutics, Inc. | COM | – | $3.24M |
| BLUEbluebird bio, Inc. | COM | – | $3.20M |
| KRROKorro Bio, Inc. | COM | $958.0K | $1.90M |
| GOSSGossamer Bio, Inc. | COM | – | $2.77M |
| XENEXenon Pharmaceuticals Inc. | COM | – | $2.69M |
| ICPTIntercept Pharmaceuticals, Inc. | COM | – | $2.31M |
| Trillium Therapeutics Inc.89620X506 | COM NEW | – | $2.15M |
| EYPTEyePoint, Inc. | COM NEW | – | $2.12M |
| RAREUltragenyx Pharmaceutical Inc. | COM | $2.09M | – |
| CLOVClover Health Investments, Corp. | COM CL A | – | $1.89M |
| CVMCel Sci Corp | COM PAR NEW | – | $1.63M |
| CMRXChimerix Inc | COM | – | $1.45M |
| SRRKScholar Rock Holding Corp | COM | – | $1.43M |
| WVEWave Life Sciences, Inc. | SHS | – | $1.40M |
| AUPHAurinia Pharmaceuticals Inc. | COM | – | $1.30M |
| TDOCTeladoc Health, Inc. | COM | $1.18M | – |
| CRISCuris Inc | COM NEW | – | $1.13M |
| VCELVericel Corp | COM | – | $439.0K |
| LEGNLegend Biotech Corp | SPONSORED ADS | $44.0K | – |
| CGENCompugen Ltd | ORD | $4.00K | – |